Neuronal insulin resistance from high-fat diet impairs glucose uptake, forcing ketone metabolism that destabilizes microtubules.

The Foundational Concept: The brain is not insulin-insensitive it's a major insulin target. When neurons become resistant, metabolic starvation triggers structural collapse.
The Mechanism:
Dietary Trigger: Chronic high-fat, high-sugar intake elevates circulating free fatty acids and inflammatory cytokines. These activate stress kinases (JNK, IKKβ) in neurons that phosphorylate IRS-1 at inhibitory serine sites.
Insulin Signaling Collapse: Neuronal insulin receptors fail to activate PI3K/AKT pathway. GLUT4 and GLUT3 translocation to synaptic membranes decreases by 40-50%, starving synapses of glucose during high-demand periods.
Metabolic Shift: Neurons attempt compensation by oxidizing ketone bodies. While ketones preserve ATP, they cannot support pentose phosphate pathway critical for NADPH production and antioxidant defense.
Microtubule Destabilization: Insulin signaling normally activates mTOR and GSK3�� regulation. Without insulin, GSK3�� becomes overactive, hyperphosphorylating tau. Hyperphosphorylated tau detaches from microtubules, causing depolymerization.
Axonal Transport Failure: Destabilized microtubules cannot transport mitochondria, vesicles, or neurotrophic factors to distal synapses. Synaptic degeneration begins.
Amyloid Connection: Insulin normally competes with insulin-degrading enzyme (IDE). Low insulin signaling frees IDE to degrade less amyloid but IDE preferentially degrades insulin, allowing amyloid accumulation.
The T2D-AD Link:
Type 2 diabetics have 2-3x increased AD risk
Intranasal insulin improves cognition in some trials
Brain insulin resistance precedes cognitive decline by years
Therapeutic Angles:
Intranasal insulin bypassing peripheral metabolism
GLP-1 agonists (semaglutide) with brain penetration
Ketogenic diets providing alternative fuel while preserving microtubules
GSK3�� inhibitors stabilizing tau-microtubule interactions
This reframes Alzheimer's as type 3 diabetes metabolic failure driving structural pathology.